| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.43 | 0.01 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.4 | 0.01 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.4 | 0.01 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.3 | 0.02 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |